The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

Tobacco and coffee contain bioactive compounds that may reduce Parkinson's disease risk by targeting key pathways such as MAO ...

C2N Diagnostics LLC, a St. Louis-based biotechnology firm that developed blood-based tests for Alzheimer's and other neurological diseases, has received a grant from The Michael J. Fox Foundation for ...

Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

Teams within the Scientific Tracks will join the ASAP CRN, an international, multidisciplinary, and multi-institutional network of collaborating investigators working to address high-priority research ...

The proteins were gathered from cerebrospinal ... Researchers Identify a Potential Biomarker of Parkinson's Disease Progression Nov. 12, 2024 — Researchers have identified a potential biomarker ...